Profile data is unavailable for this security.
About the company
Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based technology. The Hemopurifier is a United States Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption application related to the treatment of life-threatening viruses that are not addressed with approved therapies.
- Revenue in USD (TTM)0.00
- Net income in USD-12.21m
- Incorporated1991
- Employees14.00
- LocationAethlon Medical Inc11555 Sorrento Valley Road, Suite 203SAN DIEGO 92121United StatesUSA
- Phone+1 (858) 459-7800
- Websitehttps://www.aethlonmedical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AccuStem Sciences Inc | 0.00 | -1.74m | 3.90m | 3.00 | -- | -- | -- | -- | -0.1537 | -0.1537 | 0.00 | -0.2309 | 0.00 | -- | -- | 0.00 | -1,168.46 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 45.26 | -- | -- | -- |
| SINTX Technologies Inc | 2.78m | -8.88m | 3.94m | 43.00 | -- | 0.0138 | -- | 1.42 | -389.94 | -389.94 | 74.21 | 383.24 | 0.138 | 1.62 | 5.84 | 64,534.88 | -44.03 | -45.71 | -57.11 | -57.36 | 67.96 | 58.47 | -318.99 | -681.80 | 1.67 | -- | 0.0229 | -- | 68.29 | 94.24 | 49.75 | -- | 54.10 | -- |
| Arch Therapeutics Inc | 130.55k | -8.43m | 4.00m | 8.00 | -- | -- | -- | 30.64 | -3.68 | -3.68 | 0.0425 | -2.45 | 0.0833 | 0.0637 | -- | 16,318.75 | -538.25 | -188.28 | -- | -804.63 | 33.37 | -- | -6,458.14 | -26,945.92 | 0.0164 | -1.27 | -- | -- | 383.83 | -- | -32.35 | -- | -21.76 | -- |
| Venus Concept Inc | 73.30m | -37.39m | 4.07m | 304.00 | -- | -- | -- | 0.0555 | -6.69 | -6.69 | 13.12 | -3.54 | 0.7409 | 1.06 | 2.21 | 241,125.00 | -37.61 | -32.71 | -56.83 | -44.01 | 68.37 | 68.16 | -50.77 | -48.50 | 1.35 | -3.44 | 1.40 | -- | -23.26 | 28.31 | 14.76 | -- | -35.08 | -- |
| Encision Inc | 6.59m | -691.78k | 4.27m | 22.00 | -- | 2.34 | -- | 0.6489 | -0.0588 | -0.0588 | 0.5595 | 0.154 | 1.66 | 2.09 | 7.27 | 299,357.70 | -17.41 | -3.03 | -24.73 | -4.13 | 47.62 | 51.25 | -10.50 | -1.89 | 0.8393 | -10.27 | 0.1272 | -- | -10.38 | -5.64 | -113.55 | -- | -9.54 | -- |
| Dror Ortho-Design Inc | 0.00 | -4.83m | 4.46m | 4.00 | -- | 1.87 | -- | -- | -0.0115 | -0.0115 | 0.00 | 0.0048 | 0.00 | -- | -- | -- | -357.10 | -140.50 | -595.21 | -- | -- | -- | -- | -118,188.00 | -- | -- | 0.00 | -- | -- | -- | -1,896.02 | -- | -- | -- |
| Sharps Technology Inc | 0.00 | -8.71m | 4.54m | 3.00 | -- | 0.6615 | -- | -- | -0.6204 | -0.6204 | 0.00 | 0.4378 | 0.00 | -- | -- | -- | -74.67 | -- | -95.84 | -- | -- | -- | -- | -- | 0.492 | -- | 0.00 | -- | -- | -- | -112.12 | -- | -- | -- |
| Reflect Scientific Inc | 1.27m | -343.17k | 4.67m | 7.00 | -- | 2.51 | -- | 3.68 | -0.004 | -0.004 | 0.0148 | 0.0217 | 0.5129 | 0.6184 | 5.72 | 181,111.40 | -13.88 | 11.10 | -16.43 | 13.21 | 56.06 | 62.48 | -27.07 | 10.00 | 2.21 | -- | 0.00 | -- | -47.09 | -6.99 | -613.46 | -- | -- | -- |
| ReShape Lifesciences Inc | 8.34m | -10.92m | 4.73m | 31.00 | -- | 1.04 | -- | 0.5674 | -2.30 | -2.30 | 0.7319 | 0.1933 | 0.6781 | 0.8178 | 4.52 | 268,871.00 | -88.83 | -136.06 | -162.20 | -194.32 | 65.85 | 56.30 | -130.99 | -408.36 | 1.26 | -- | 0.00 | -- | -22.79 | -0.9474 | 75.36 | -- | -49.29 | -- |
| Nu-Med Plus Inc | 0.00 | -119.16k | 4.75m | 2.00 | -- | -- | -- | -- | -0.0014 | -0.0014 | 0.00 | -0.002 | 0.00 | -- | -- | 0.00 | -350.01 | -447.69 | -- | -- | -- | -- | -- | -- | -- | -22.74 | -- | -- | -- | -- | 3.56 | -- | -- | -- |
| Aethlon Medical, Inc. | 0.00 | -12.21m | 5.11m | 14.00 | -- | 0.1676 | -- | -- | -4.87 | -4.87 | 0.00 | 2.19 | 0.00 | -- | -- | 0.00 | -94.80 | -76.25 | -108.90 | -85.78 | -- | -- | -- | -2,246.87 | -- | -- | 0.00 | -- | -100.00 | -- | -1.43 | -- | -- | -- |
| Caduceus Software Systems Corp | 0.00 | -117.60k | 5.35m | 0.00 | -- | -- | -- | -- | -0.0004 | -0.0004 | 0.00 | -0.0004 | 0.00 | -- | -- | -- | -402.19 | -11,090.31 | -- | -- | -- | -- | -- | -- | -- | -76.88 | -- | -- | -- | -- | -20,519.89 | -- | -- | -- |
| ADM Tronics Unlimited Inc | 2.97m | -877.23k | 5.35m | 7.00 | -- | 7.73 | -- | 1.81 | -0.013 | -0.013 | 0.0439 | 0.0102 | 1.13 | 4.89 | 7.04 | -- | -33.56 | -15.22 | -58.66 | -22.09 | 37.65 | 41.15 | -29.58 | -18.58 | 0.8015 | -316.56 | 0.4233 | -- | -19.35 | -0.3572 | -810.74 | -- | -- | -- |
| Sonendo Inc | 40.19m | -57.74m | 5.39m | 216.00 | -- | 0.2197 | -- | 0.1341 | -0.6125 | -0.5552 | 0.426 | 0.3482 | 0.4448 | 2.07 | 7.58 | 186,055.60 | -63.91 | -- | -78.82 | -- | 27.64 | -- | -143.67 | -- | 2.14 | -10.83 | 0.4695 | -- | 5.30 | -- | -6.78 | -- | -- | -- |
| Predictive Oncology Inc | 1.96m | -14.78m | 5.66m | 34.00 | -- | 1.38 | -- | 2.89 | -3.66 | -3.66 | 0.4853 | 0.9977 | 0.1099 | 1.71 | 4.95 | 57,642.65 | -82.89 | -91.80 | -108.54 | -126.29 | 64.18 | 64.64 | -754.19 | -1,419.99 | 1.35 | -- | 0.0093 | -- | 18.24 | 4.75 | 45.67 | -- | 5.44 | -- |
| Biomerica Inc | 5.41m | -6.35m | 5.84m | 62.00 | -- | 0.748 | -- | 1.08 | -0.3789 | -0.3789 | 0.3224 | 0.4642 | 0.5827 | 2.28 | 5.74 | 87,180.80 | -68.45 | -43.55 | -83.73 | -50.32 | 11.41 | 15.75 | -117.46 | -55.86 | 3.37 | -- | 0.00 | -- | -71.71 | -0.8229 | -57.58 | -- | -9.76 | -- |
Data as of Jul 26 2024. Currency figures normalised to Aethlon Medical Inc's reporting currency: US Dollar USD
0.47%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2024 | 21.22k | 0.15% |
| Geode Capital Management LLCas of 31 Mar 2024 | 20.27k | 0.15% |
| Baader Bank AG (Investment Management)as of 30 Jun 2024 | 13.25k | 0.10% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 7.34k | 0.05% |
| Group One Trading LPas of 31 Mar 2024 | 1.22k | 0.01% |
| Tower Research Capital LLCas of 31 Mar 2024 | 1.14k | 0.01% |
| Osaic Wealth, Inc. (Investment Management)as of 31 Mar 2024 | 299.00 | 0.00% |
| Wells Fargo Clearing Services LLCas of 31 Mar 2024 | 211.00 | 0.00% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024 | 89.00 | 0.00% |
| UBS Securities LLCas of 31 Mar 2024 | 73.00 | 0.00% |
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
